In terms of revenue, the Global Biopreservation Market is expected to reach by 2030, growing at a CAGR (Compound Annual Growth Rate) of 29.1% from 2023 to 2030.
is a crucial process that preserves biological entities' structural and functional integrity across diverse temperature conditions, such as stem cells, DNA, tissues, and organs. This preservation extends their viability outside their natural environment. Technological advancements encompass innovations like microarrays and integrating various predictive models, including hybrid models and different API algorithms. These innovations collectively streamline the process, curtailing time, cost, and complexity.
Moreover, the emergence of multiplex cellular imaging platforms is poised to amplify 's capabilities. This enhancement aids in comprehending the progression of diseases. It offers valuable insights for suitable diagnostic and treatment strategies, particularly within specialized medical domains such as cardiology, gynecology, and point-of-care applications.
Recently, there has been a notable increase in the utilization of for advancing biological products across various sectors, including immunotherapies, vaccine production, antibody synthesis, enzyme technology, and the production of biologically derived chemicals. This trend is spurred by the escalating prevalence of chronic diseases on a global scale. To illustrate, the Centers for Disease Control and Prevention highlight that cardiovascular diseases and cancer are among the foremost contributors to disease-related fatalities in adults in the United States.
Key Highlights from the Report
- Based on Product, the Equipment segment dominates the Biopreservation market owing to its growing need for bio-banking to preserve stem cells, DNA, plasma, and tissue culture.
- Based on Application, the Biobanking segment accounted for the substantial growth of the market in 2022 owing to the increasing demand for personalized & precision medicine, advancements in techniques, and the rising prevalence of chronic diseases.
- Based on Region, North America holds the significant market share within the Biopreservation market in 2022, owing to the presence of advancement in biomedical research and the development of advanced therapies.
Progress in regenerative medicine exerts a significant impact on the global market. is pivotal in facilitating regenerative medicine's success by safeguarding the viability and operational efficacy of cells, tissues, and engineered constructs. Regenerative medicine aims to rejuvenate or substitute damaged tissues or organs through cell-based therapies, tissue engineering, and innovative approaches. Additionally, these techniques are indispensable for sustaining the viability and potency of stem cells during storage and transit.
Furthermore, cryopreservation techniques, encompassing freezing and vitrification, are commonly employed to conserve stem cells for subsequent therapeutic or research applications. Noteworthy advancements in protocols for preserving stem cells and developing effective cryoprotectants have substantially heightened stem cells' viability and functional integrity after thawing. This progress has significantly contributed to the expansion of the market.
North America led the innovative coatings market in 2022. This can be attributed to the advancements in biomedical research and the progression of advanced therapies. Moreover, the escalating chronic conditions that necessitate medical interventions fosters a demand for in the region, thus bolstering its market presence. These activities are anticipated to significantly broaden the range of available products within the market, consequently driving growth. The United States is expected to experience a substantial increase in the market, primarily due to the involvement of governmental entities and various bio-banking institutes, which facilitate the adoption of techniques. For example, the National Institutes of Health (NIH) funding activities support biospecimen collection in biorepositories and biobanks, while the National Cancer Institute (NCI) manages related bio-banking programs. These biobanks are pivotal in supporting research and clinical trial initiatives within the country, amplifying the demand for advanced techniques.
The Global Biopreservation Market is Segmented as follows
- Laboratory Information Management System (LIMS)
- Regenerative Medicine
- Regenerative Medicine
- Drug Discovery
- North America
- Asia Pacific
- Latin America
- Middle East and Africa
List of the Key Players of the Global Biopreservation Market is
BioCision LLC (U.S.), BioLife Solutions Inc. (U.S.), Cesca Therapeutics Inc. (U.S.), Core Dynamics Ltd. (U.S.), Custom Biogenic Systems Inc. (U.S.), Lifeline Scientific Inc. (U.S.), Merck KGaA (Germany), Princeton CryoTech Inc. (U.S.), VWR International (U.S.), Azenta US Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), MVE Biological Solutions (U.S.)
The Global Biopreservation Market Scope can be Tabulated as below
|Market Size Provided for Years||2017 - 2030|
|Historic Years||2017 - 2021|
|Forecast Years||2023 - 2030|
|Regions & Counties Covered||
|Report Coverage||Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, technology landscape, patent analysis, market attractiveness analysis by segments and North America, company market share analysis, and COVID-19 impact analysis|